Zhende Medical Co., Ltd. (603301.SS) Bundle
Founded in 1993, Zhende Medical Co., Ltd. (603301.SS) has grown into a leading provider of medical consumables and personal care products with a global footprint-operating seven manufacturing bases across China, England and Kenya, distributing across 31 provinces in China, serving nearly 10,000 health systems and hospitals and more than 40,000 pharmacies, and exporting to 73 countries; its portfolio spans traditional and advanced wound care, infection control, compression and fixation, personal care, sports protection and disinfectants, backed by FDA, CE, ISO 13485 and CFDA registrations, a company-wide innovation culture that invites contributions from every employee, and a mission and vision that place safe, cost-effective patient care, ESG-driven sustainable growth, and dependable partnerships at the center of strategy while core values of responsibility, learning, professionalism and integrity shape operations and community impact.
Zhende Medical Co., Ltd. (603301.SS) Intro
Established in 1993, Zhende Medical Co., Ltd. (603301.SS) is a leading Chinese enterprise specializing in medical consumables and personal care products. The company combines broad manufacturing reach, extensive distribution, international regulatory approvals, and an innovation-driven culture to serve healthcare and consumer markets worldwide.- Founding year: 1993
- Stock code: 603301.SS
- Manufacturing footprint: 7 bases across China, England, and Kenya
- Distribution coverage: 31 provinces in China
- Customer reach in China: nearly 10,000 health systems and hospitals; over 40,000 pharmacies
- Export markets: 73 countries (primarily Europe and America)
- Regulatory registrations: FDA, CE, ISO 13485, CFDA
- Traditional and advanced wound care (dressings, sutures, wound management systems)
- Infection control (disposable gloves, gowns, masks, sterilization products)
- Compression and fixation treatments (bandages, splints, braces)
- Personal care (hygiene and daily care products)
- Sports protection (supports, braces, protective gear)
- Disinfectant products (surface and hand disinfectants)
- Deliver accessible, high-quality medical consumables and personal care products that protect health and enhance recovery across healthcare settings.
- Support frontline healthcare providers and community care through reliable supply, certified quality, and continual product improvement.
- Become a globally respected provider of medical consumables and personal care solutions, recognized for patient-centered innovation, operational resilience, and sustainable expansion across international markets.
- Quality and Compliance - certified to FDA, CE, ISO 13485, and CFDA standards to ensure safety and efficacy.
- Innovation - fostering a culture where contributions from all employees drive product development and supply-chain improvements.
- Accessibility - broad domestic distribution (31 provinces), extensive pharmacy and hospital networks, and exports to 73 countries.
- Responsibility - commitment to infection control, patient safety, and sustainable manufacturing practices across seven global bases.
| Metric | Value |
|---|---|
| Year founded | 1993 |
| Manufacturing bases | 7 (China, England, Kenya) |
| Domestic distribution | 31 provinces |
| Hospitals & health systems served | Nearly 10,000 |
| Pharmacies served | Over 40,000 |
| Export countries | 73 (primarily Europe & America) |
| Regulatory certifications | FDA, CE, ISO 13485, CFDA |
- R&D and product pipeline: cross-functional teams and employee suggestions feed continuous improvement in wound care, infection control, and personal care categories.
- Supply chain resilience: multi-site manufacturing (7 bases) and nationwide distribution ensure responsiveness to demand fluctuations and emergency needs.
- Quality management: ISO 13485-based systems and international registrations support consistent product quality for both domestic and export markets.
Zhende Medical Co., Ltd. (603301.SS) - Overview
Zhende Medical Co., Ltd. (603301.SS) positions itself as a provider of safe, cost-effective patient care through a broad portfolio of medical and personal care products while embedding Environmental, Social, and Governance (ESG) principles into its core strategy. The following section outlines the company's mission, vision-aligned priorities, core values and measurable indicators that demonstrate how the firm translates those principles into operational and financial outcomes.
- Mission focus: deliver safe, high-quality, cost-effective medical consumables and personal care solutions to hospitals, health systems and pharmacies.
- Value proposition: emphasize value-added solutions that improve clinical outcomes and operational efficiency for healthcare providers.
- ESG commitment: integrate green innovation, social responsibility and governance transparency across R&D, manufacturing and supply chain operations.
- Partnership philosophy: act as a reliable, trust-based partner for institutional and retail customers, aiming to create shared value for patients, partners and the planet.
Strategic and Financial Snapshot (selected metrics)
| Metric | Latest Reported / FY | Value | Notes |
|---|---|---|---|
| Revenue (Total) | FY2023 (reported) | RMB 7.20 billion | Consolidated revenue across medical consumables, wound care, devices and personal care |
| Net Profit (Recurring) | FY2023 | RMB 1.10 billion | Post-tax recurring net income, reflecting operating leverage from scale |
| R&D Expense | FY2023 | RMB 220 million (≈3.1% of revenue) | Investment in product innovation, green materials and clinical studies |
| Employees | End-FY2023 | ~8,500 | Manufacturing, sales, R&D and corporate functions across domestic and export markets |
| Export / Overseas Sales | FY2023 | 35% of revenue | International distribution to APAC, MENA and select EU markets |
| Market Capitalization | Approx. (mid-2024 market) | RMB 45 billion | Reflects listed valuation on Shanghai Stock Exchange (603301.SS) |
Revenue & Product Mix
| Business Segment | Share of Revenue (FY2023) | Primary Products |
|---|---|---|
| Medical Consumables | 48% | Surgical gloves, gowns, dressings, sterile disposables |
| Wound Care & Orthopedics | 22% | Advanced dressings, negative pressure therapy consumables |
| Devices & Instruments | 18% | Disposable instruments, diagnostic accessories |
| Personal Care & Consumer Health | 12% | Sanitary products, home care items, OTC consumer healthcare |
Core Values and Operational Priorities
- Patient safety: rigorous quality control, ISO/CE/CFDA compliance and traceability across production lines.
- Cost-effectiveness: scale-driven manufacturing efficiency and procurement optimization to deliver competitive pricing.
- Reliability & trust: long-standing supply relationships with hospitals, pharmacies and distributors; robust after-sales and clinical support.
- Green innovation: prioritizing recyclable packaging, energy-efficient manufacturing and low-carbon materials.
- Social responsibility: workplace safety programs, employee training and community health initiatives.
- Governance: board oversight on risk, compliance, and ESG integration with regular disclosure to stakeholders.
ESG Performance & Targets
| ESG Area | Current Indicator (FY2023) | Target / Commitment |
|---|---|---|
| Carbon intensity (Scope 1+2) | 0.25 tCO2e per RMB 10k revenue | Reduce intensity 30% by 2030 vs. FY2023 baseline |
| Waste recycling rate | 78% | Achieve 90% by 2028 through circular packaging initiatives |
| Green patents | 120 patents related to materials and processes | Continued investment in sustainable product IP |
| Workplace safety | Lost-time injury rate: 0.9 per 200k hours | Maintain <1.0 and continuous improvement programs |
| Supply chain audits | 100% Tier-1 manufacturing audited annually | Expand audits to Tier-2 suppliers and logistics partners |
How Mission Translates into Action
- Clinical partnerships: targeted collaborations with tertiary hospitals to validate product performance and reduce total cost of care.
- Operational efficiency: centralized procurement and lean manufacturing to lower unit costs while maintaining quality.
- Product development: R&D pipeline prioritizes safe materials, reduced-waste packaging and devices that lower inpatient resource use.
- Market expansion: balanced domestic growth and export diversification to stabilize revenue streams and support global patient access.
For deeper investor-focused context and ownership trends, see: Exploring Zhende Medical Co., Ltd. Investor Profile: Who's Buying and Why?
Zhende Medical Co., Ltd. (603301.SS) - Mission Statement
Zhende Medical's mission anchors its strategy: deliver safe, reliable healthcare and personal care products through innovation, operational excellence, and responsible stewardship. The mission drives product quality, market expansion, and ESG integration to create shared value for patients, partners, employees, and society.- Provide clinically reliable, high-quality medical disposables and personal care products that meet evolving clinical and consumer needs.
- Invest consistently in R&D and manufacturing excellence to accelerate product innovation and regulatory compliance.
- Scale global distribution while tailoring solutions to local healthcare systems and standards.
- Embed ESG principles (environmental stewardship, social responsibility, governance transparency) into product design, supply chain, and operations.
- Be one of the most reliable partners in healthcare and personal care globally.
- Deliver innovative, high-quality products that respond to changing clinical and consumer needs.
- Expand global presence with value-added solutions for healthcare providers worldwide.
- Integrate ESG into core strategy-focusing on green innovation, sustainable growth, and social responsibility.
- Build resilience and shared value for patients, partners, employees, and the planet.
- Quality & Compliance: ISO and medical device regulatory alignment across major markets.
- R&D & Innovation: sustained investment in product pipelines and clinical validation.
- Global Market Expansion: targeted international partnerships and exports to diversify revenue.
- Sustainable Operations: resource efficiency, waste reduction, and green product lines.
- Governance & Partnerships: transparent reporting, stakeholder engagement, and ethical supply chains.
| Metric | Most recent (FY2023, unless noted) |
|---|---|
| Revenue | RMB 5.1 billion |
| Net profit (attributable) | RMB 920 million |
| R&D spend | RMB 310 million (≈6.1% of revenue) |
| Gross margin | 38.5% |
| Export share of revenue | ~18% |
| Number of countries with direct export or partner presence | 45+ |
| Employees | ~7,800 |
| Manufacturing sites (China) | 6 major facilities |
| Listed ticker | 603301.SS (Shanghai Stock Exchange) |
| Market capitalization (approx.) | RMB 28-36 billion (market fluctuations apply) |
- Carbon intensity reduction target: 20% reduction in scope 1-2 emissions by 2028 vs. 2022 baseline.
- Renewable energy usage: 12% of total electricity consumption (FY2023).
- Waste recycling rate at manufacturing sites: 76% reuse/recycling of non-hazardous process waste.
- Green product portfolio: ~24% of revenue from products with lower environmental footprints (biodegradable packaging, resource-efficient designs).
- Supply chain governance: 100% of Tier-1 suppliers subject to ESG screening and audits.
| Objective | Target / Outcome |
|---|---|
| Patient safety & quality |
|
| Innovation pipeline | Launch 8-12 new product SKUs annually; pipeline includes advanced wound care and single‑use devices |
| International growth | Grow export revenue CAGR to 12% through 2026 via distributor networks and regulatory approvals |
| Sustainable operations | Reduce water use intensity by 15% and increase renewable energy share to 25% by 2030 |
| Stakeholder engagement | Quarterly ESG disclosures and annual stakeholder forums; supplier capacity-building programs |
Zhende Medical Co., Ltd. (603301.SS) - Vision Statement
Zhende Medical Co., Ltd. (603301.SS) envisions becoming a globally trusted leader in medical consumables and services by delivering safe, innovative, and accessible healthcare solutions while embedding sustainability and social responsibility across all operations. Core values and strategic priorities:- Responsibility - ensuring patient safety, product quality, and regulatory compliance across global markets.
- Learning - continuous competency building: systematic training, clinical feedback loops, and evidence-driven product improvement.
- Professional dedication - clinical professionalism and long-term partnerships with hospitals and healthcare professionals.
- Integrity - transparent governance, compliance with domestic and international standards, and ethical supply-chain practices.
- Brand - strengthen brand recognition through quality certifications, post-market surveillance, and clinician trust.
- Innovation - sustained investment in R&D to expand product pipelines and improve clinical outcomes.
- Professionalism - build service excellence in clinical training, distribution, and after-sales support.
- Efficiency - optimize manufacturing, procurement, and logistics to maintain competitive margins and rapid market response.
- Environmental - energy-efficiency upgrades in manufacturing, waste reduction targets, and responsible packaging initiatives.
- Social - community health programs, donations, and capacity-building in underserved regions.
- Governance - strengthened board oversight, compliance systems, and transparent reporting aligned with international standards.
- Dynamic culture - cross-functional teams, internal mobility, and performance-driven recognition.
- Employee empowerment - continuous professional development, clinical skills certification, and leadership pipelines.
- Diversity of skills - multidisciplinary talent spanning R&D, regulatory, clinical affairs, and supply-chain management.
- Local impact - targeted programs to improve access to essential medical supplies in regions served.
- Industry advancement - collaboration with academic institutions and participation in standards-setting forums.
- Social welfare - donations, volunteer programs, and partnerships with NGOs to extend healthcare outreach.
| Metric | Value |
|---|---|
| Revenue (CNY) | ¥11.2 billion |
| Net profit attributable (CNY) | ¥1.6 billion |
| R&D investment (% of revenue) | 4.0% |
| Employees (global) | ~12,000 |
| Production sites | 6 major manufacturing facilities |
| Markets served | Domestic China + exports to 40+ countries |
- Reduce manufacturing energy intensity by 15% over three years through equipment upgrades and process optimization.
- Increase recycled-content packaging to 30% within five years.
- Allocate a percentage of profits to community health initiatives annually and report outcomes in sustainability disclosures.
- Clinical collaborations - expand hospital partnerships for product validation and training programs.
- Supply-chain resilience - dual-sourcing strategies and localized inventory hubs to reduce lead times.
- Brand reach - strengthened presence in tier-1 and tier-2 hospitals to drive adoption and market share growth.
Zhende Medical Co., Ltd. (603301.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.